Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunoglobulin expression levels as biomarker for proteasome inhibitor response

Immunoglobulin expression levels as biomarker for proteasome inhibitor response

US Patent 10870889 · Granted Dec 22, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibit2024
Combination therapy with peptide epoxyketones2020
Combination therapy with peptide epoxyketones2020
Liposomal compositions of epoxyketone-based proteasome inhibitors2018
Combination therapy with peptide epoxyketones2016
Modified release formulations for oprozomib2016
Methods for microvesicle isolation and selective removal2015
Use of peptide epoxyketones for metastasis suppression2014